The C terminus of NS1 protein of influenza A/WSN/1933(H1N1) virus modulates antiviral responses in infected human macrophages and mice

References

1. Ayllon J., García-Sastre A. 2015; The NS1 protein: a multitasking virulence factor. Curr Top Microbiol Immunol 386:73–107[PubMed]
   [Google Scholar]
2. Denisova O.V., Kakkola L., Feng L., Stenman J., Nagaraj A., Lampe J., Yadav B., Aittokallio T., Kaukinen P. 2012; Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection. J Biol Chem 287:35324–35332 [View Article][PubMed]
   [Google Scholar]
3. Denisova O.V., Söderholm S., Virtanen S., Von Schantz C., Bychkov D., Vashchinkina E., Desloovere J., Tynell J., Ikonen N. 2014; Akt inhibitor MK2206 prevents influenza pH1N1 virus infection in vitro. Antimicrob Agents Chemother 58:3689–3696 [View Article][PubMed]
   [Google Scholar]
4. Dundon W.G., Capua I. 2009; A closer look at the NS1 of influenza virus. Viruses 1:1057–1072 [View Article][PubMed]
   [Google Scholar]
5. Hale B.G., Randall R.E., Ortín J., Jackson D. 2008; The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89:2359–2376 [View Article][PubMed]
   [Google Scholar]
6. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R.G. 2000; A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97:6108–6113 [View Article][PubMed]
   [Google Scholar]
7. Jackson D., Hossain M.J., Hickman D., Perez D.R., Lamb R.A. 2008; A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A 105:4381–4386 [View Article][PubMed]
   [Google Scholar]
8. Jalovaara P., Bychkov D., Ahtiainen L., Kallio-Kokko H., Valkonen M., Kantele A., Mattila P., Almusa H., Kallioniemi O., Kainov D. 2014; Genetic instability of influenza pH1N1 viruses. Genome Announc 2:e00841–14 [View Article][PubMed]
   [Google Scholar]
9. Kakkola L., Denisova O.V., Tynell J., Viiliäinen J., Ysenbaert T., Matos R.C., Nagaraj A., Ohman T., Kuivanen S. 2013; Anticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected mice. Cell Death Dis 4:e742 [View Article][PubMed]
   [Google Scholar]
10. Kong W., Liu L., Wang Y., He Q., Wu S., Qin Z., Wang J., Sun H., Sun Y. 2015; C-terminal elongation of NS1 of H9N2 influenza virus induces a high level of inflammatory cytokines and increases transmission. J Gen Virol 96:259–268 [View Article][PubMed]
    [Google Scholar]
11. Lakspere T., Tynell J., Kaloinen M., Vanlede M., Parsons A., Ikonen N., Kallio-Kokko H., Kantele A., Mattila P. 2014; Full-genome sequences of influenza A(H1N1)pdm09 viruses isolated from Finnish patients from 2009 to 2013. Genome Announc 2:e01004–e01013 [View Article][PubMed]
    [Google Scholar]
12. Müller K.H., Kakkola L., Nagaraj A.S., Cheltsov A.V., Anastasina M., Kainov D.E. 2012; Emerging cellular targets for influenza antiviral agents. Trends Pharmacol Sci 33:89–99 [View Article][PubMed]
    [Google Scholar]
13. Richt J.A., García-Sastre A. 2009; Attenuated influenza virus vaccines with modified NS1 proteins. Curr Top Microbiol Immunol 333:177–195[PubMed]
    [Google Scholar]
14. Soubies S.M., Volmer C., Guérin J.L., Volmer R. 2010; Truncation of the NS1 protein converts a low pathogenic avian influenza virus into a strong interferon inducer in duck cells. Avian Dis 54:(Suppl)527–531 [View Article][PubMed]
    [Google Scholar]